Publications by authors named "Alisala Kashinatham"

Irofulven is a semi-synthetic derivative of Illudin S, a toxic sesquiterpene isolated from the mushroom Omphalotus illudens. Irofulven has displayed significant antitumor activity in various clinical trials but displayed a limited therapeutic index. A new derivative of irofulven was prepared by reacting hydroxyurea with irofulven under acidic conditions.

View Article and Find Full Text PDF

CelTherm is a biochemical process to produce renewable fuels and chemicals from lignocellulosic biomass. The present study's objective was to determine the level of treatment/purity of the microbial triacylglyceride oil (TAG) necessary to facilitate fuel production. After a unique microbe aerobically synthesizes TAG from biomass-derived sugars, the microbes were harvested and dried then crude TAG was chemically extracted from the residual biomass.

View Article and Find Full Text PDF

AMPA receptors (AMPARs) are an important therapeutic target in the CNS. A series of substituted benzobistriazinone, benzobispyrimidinone and related derivatives have been prepared with high potency and selectivity for the allosteric binding site of AMPARs. Further improvements have been made to previously reported series of positive AMPAR modulators and these compounds exhibit excellent in vivo activity and improved in vivo metabolic stability with up to 100% oral bioavailability in rat.

View Article and Find Full Text PDF
Article Synopsis
  • Illudin S and M are toxic compounds from the fungus Omphalotus illudens, but their derivatives, specifically acylfulvene, show strong potential as antitumor agents.
  • In clinical trials, irofulven significantly improved survival rates for patients with hard-to-treat metastatic prostate cancer.
  • Researchers have created various derivatives of irofulven that maintain essential functional groups, demonstrating effective activity against cancer cells while being relatively safe for non-target cells.
View Article and Find Full Text PDF